Physician

Qaiser Niaz, MD

According to 2025 Medicare claims, Qaiser Niaz, MD (NPI: 1528056389) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is EPIC CARE (NPI: 1780107797; TIN: 821993796) and primary practice location at 94546-5314. Niaz is affiliated with the Aledade 147 Hill Physicians MSSP Basic E (ACO ID: A5230), participating under the MSSP model.

Niaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 684 traditional Medicare patients, billed 199,781 HCPCS/CPT codes, and received $3,978,961 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,471 prescription claims across 234 beneficiaries totaling $3,226,580 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 11 claims. Open Payments data shows 167 records totaling $4,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $606,723 to $3,978,961. Similarly, Part D prescription costs have risen steadily, from $338,307 to $3,226,580. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,678 to $1,026.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $606,723 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,602,229 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,846,392 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,685,811 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,835,171 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,759,838 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,285,105 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,988,803 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,395,653 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,978,961 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201538585,614$606,723
2016467237,518$1,602,229
2017497247,539$1,846,392
2018507162,057$1,685,811
2019565156,925$1,835,171
2020525174,061$1,759,838
2021621292,414$3,285,105
2022580249,094$2,988,803
2023632246,668$3,395,653
2024684199,781$3,978,961

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.5M2015 Drug cost: $338,307 (USD; Tot_Drug_Cst)2016 Drug cost: $645,223 (USD; Tot_Drug_Cst)2017 Drug cost: $881,007 (USD; Tot_Drug_Cst)2018 Drug cost: $1,367,102 (USD; Tot_Drug_Cst)2019 Drug cost: $2,463,799 (USD; Tot_Drug_Cst)2020 Drug cost: $2,563,248 (USD; Tot_Drug_Cst)2021 Drug cost: $2,055,224 (USD; Tot_Drug_Cst)2022 Drug cost: $2,727,467 (USD; Tot_Drug_Cst)2023 Drug cost: $3,487,974 (USD; Tot_Drug_Cst)2024 Drug cost: $3,226,580 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201570477$338,307
2016123792$645,223
2017121788$881,007
2018121893$1,367,102
2019150995$2,463,799
20201591,060$2,563,248
20211821,261$2,055,224
20222071,340$2,727,467
20232291,477$3,487,974
20242341,471$3,226,580

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$17K$34K2015 Medicare payment: $22,828 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $34,352 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $7,939 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,912 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,229 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,238 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $17,183 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $553 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R53$22,828
2016N/R117$34,352
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R70$7,939
2020N/R50$3,912
2021N/R43$3,229
2022N/R66$2,238
2023N/R60$17,183
2024N/R11$553

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more334823$119
99443Telephone medical discussion with physician, 21-30 minutes143253$118
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more196264$75
36415Insertion of needle into vein for collection of blood sample2541,197$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count196739$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TagrissoOsimertinib Mesylate481,440$773,740
ImbruvicaIbrutinib22616$360,711
LenalidomideLenalidomide23623$318,756
KisqaliRibociclib Succinate22616$285,610
VerzenioAbemaciclib21588$277,654

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R11$553

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.167$4,031Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Qaiser Niaz, MD?

Tedicare shows public-source Medicare data for Qaiser Niaz, MD (NPI 1528056389), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Qaiser Niaz, MD have ACO affiliation data?

Qaiser Niaz, MD is shown with ACO affiliation data for Aledade 147 Hill Physicians MSSP Basic E (MSSP, ACO ID A5230).

What billing organization is linked to Qaiser Niaz, MD?

Qaiser Niaz, MD is linked to EPIC CARE (billing NPI 1780107797) in the available physician profile data.

Does Qaiser Niaz, MD have Open Payments data?

Qaiser Niaz, MD has 167 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.